The Green Rush: Medicinal Cannabis in Australia

Legal cannabis is the fastest growing industry in the world forecast to grow to more than $55 billion by 2025. Research has already shown that cannabis might be beneficial in the treatment dozens of conditions including epilepsy, multiple sclerosis, chronic pain, nausea and vomiting, Parkinson’s disease, psoriasis and eczema, acne, anxiety and depression.

AgTech plays a huge role in the cannabis industry and start-ups are already reaping significant rewards. But what does the future hold? As one of the only countries in the world with Federally-legal medicinal cannabis, Australia is at the forefront of this new and exciting opportunity.

Join Agtech Melbourne for a Q&A with industry experts and guests from the medical community + your chance to secure a scholarship to Cann10 Leadership Program!

6.00pm Drinks + Networking

6:30pm Q&A with industry experts + esteemed medical professional

7.00pm: Open Questions from the Audience

7:15pm - 8.00pm: Networking

https://secure.meetupstatic.com/photos/event/3/8/4/5/600_463874405.jpeg

Prof Ian Brighthope - Founder, Nutrition Care Pharmaceuticals Pty. Ltd.
Ian is an Australian doctor with an interest in medical cannabis as a treatment option. Founding president of the Australian College of Nutritional and Environmental Medicine and founder of Nutrition Care Pharmaceuticals Pty. Ltd., a TGA licensed manufacturer of Complementary and Herbal Medicines that has developed markets in China, SE Asia and India. Ian has a sound appreciation of the scientific basis of herbal medicines, their cultivation, breeding, composition, extraction, GMP manufacturing to PICS standards, and their clinical use.

https://secure.meetupstatic.com/photos/event/3/8/3/d/600_463874397.jpeg

Abdul Rehman Mohammad, Director of Research and Regulatory Affairs: UTT Biopharma.

'A qualified pharmacologist, Abdul was encapsulated by the therapeutic opportunities present in the cannabis plant. Abdul co-founded UTT BioPharma with the aim of developing synergic therapeutics from the plant. In order to achieve this goal, Abdul has put together a team of reputable scientists at the University of Melbourne to undertake this research.'

https://secure.meetupstatic.com/photos/event/3/9/d/3/600_463874803.jpeg

• Rhys Cohen, Program Director – Cann10 Australia

Rhys is a political economist, cannabis industry expert and educator. Rhys is also the Program Director of Australia's first full-scale medicinal cannabis education program, endorsed by the Dean of Medicine at Deakin University

Cann10 Medicinal Cannabis Leadership Program

Attendees to this free event will be eligible for special scholarship rates on the upcoming Cann10 Medicinal Cannabis Leadership Program (http://cann10.com/)– the country’s first full-scale cannabis training course delivered in partnership with DeakinCo.

Running over two full weekends in September, The Medicinal Cannabis Leadership Program is ideal for anyone who wants to gain world-class knowledge of medicinal cannabis science, industry, law, or commerce. Participants include entrepreneurs, scientists, and professionals from the agricultural, life sciences, agtech and biotech industries.